介入性冠狀動脈導線的全球市場:規模，佔有率，分析(2023年～2029年):MedCore，手術數量

2022年，全球介入冠狀動脈導絲市場規模將超過4.2億美元。在預測期內，市場預計將以 1.8% 的複合年增長率擴張，到 2029 年將超過 4.75 億美元。

本報告提供全球介入性冠狀動脈導線市場相關調查，提供市場概要，以及各市場區隔，各地區趨勢，競爭情形等資訊。

目錄

介入性冠狀動脈導線市場

• 摘要整理
  • 全球介入性冠狀動脈導線市場概要
  • 競爭分析
  • 對像手術
  • 對像地區
• 簡介
• 手術數量
• 市場分析與預測
• 促進因素與阻礙因素
  • 市場促進因素
  • 市場阻礙因素
• 競爭市場佔有率分析

In 2022, the global market for interventional coronary guidewires surpassed a valuation of $420 million. Over the forecast period, it is projected to experience a compound annual growth rate (CAGR) of 1.8%, reaching a value exceeding $475 million.

The comprehensive report suite encompasses the coronary guidewire market, which plays a vital role in delivering therapies to affected regions of the coronary arterial system.

MARKET DATA INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Global Procedure Numbers by Region
• Market Drivers & Limiters
• Market Forecasts Until 2029, and Historical Data to 2019
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

GLOBAL INTERVENTIONAL CORONARY GUIDEWIRE MARKET ANALYSIS

Challenging reimbursement conditions for coronary guidewires are anticipated to result in bundled contracts and cost-saving initiatives within hospitals and labs. This trend is expected to intensify competition and lead to gradual price growth in the global market. Furthermore, the increasing adoption of specialty guidewires for crossing chronic total occlusions (CTOs) and the emergence of newer devices for complex lesions are poised to drive growth in the interventional coronary guidewire market as well as the overall interventional cardiology device market. Additionally, advancements in pre-surgery imaging techniques are likely to contribute to a decrease in the number of guidewires required per procedure over the forecast period.

GLOBAL INTERVENTIONAL CORONARY GUIDEWIRE MARKET SHARE ANALYSIS

Abbott, a prominent competitor in the interventional coronary guidewire market, has established itself as a leading player in the industry. The company's success can be attributed to its innovative offerings, such as the Hi-Torque™ device based on acquired Guidant technology, and the licensed Asahi family of coronary guidewires from Asahi Intecc. Abbott's collaboration with Asahi Intecc has further strengthened its product portfolio. Asahi Intecc is renowned for its expertise in guidewire manufacturing, and the licensed Asahi family of coronary guidewires complements Abbott's offerings. These guidewires are highly regarded for their excellent construction, flexibility, and navigational capabilities, contributing to successful interventional procedures. Boston Scientific follows closely with a diverse range of guidewires, including ChoICE™, Forte™, Luge™, Magic Torque™, Meier™, Mailman™, Platinum Plus™, PT Graphix™, PT²™, SAFARI2™, and SENTAI™ lines. Leveraging their brand recognition and extensive networks, Boston Scientific has been successful in expanding their market share. Biotronik ranks third and manufactures a variety of guidewires, including Magnum® with enhanced crossability and Cruiser® designed for multivessel treatment, which have gained popularity, particularly in Germany.

RESEARCH REGIONAL COVERAGE:

In this comprehensive report, iData Research has meticulously analyzed over 70 countries worldwide, providing extensive insights and detailed information. Each global region can be acquired as an individual report, allowing you to tailor the data according to your specific requirements. The covered regions include:

• North America (the United States and Canada)

• Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)

• Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)

• Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)

• Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)

• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)

• Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

ABOUT OUR IN-DEPTH MEDCORE RESEARCH

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis of a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

Table of Contents

Interventional Coronary guidewire Market

• 9.1. Executive Summary
  • 9.1.1. Global Interventional Coronary Guidewire Market Overview
  • 9.1.2. Competitive Analysis
  • 9.1.3. Procedures Included
  • 9.1.4. Regions Included
• 9.2. Introduction
• 9.3. Procedure Numbers
• 9.4. Market Analysis and Forecast
• 9.5. Drivers and Limiters
  • 9.5.1. Market Drivers
  • 9.5.2. Market Limiters
• 9.6. Competitive Market Share Analysis

LIST OF CHARTS

• Chart 9-1: Interventional Coronary Guidewire Market, Global, 2022 & 2029
• Chart 9-2: Angioplasty/PCI Procedures, Global, 2022
• Chart 9-3: Angioplasty/PCI Procedures by Region, Global, 2019 - 2029
• Chart 9-4: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022

LIST OF FIGURES

• Figure 9-1: Interventional Coronary Guidewire Procedures Covered
• Figure 9-2: Interventional Coronary Guidewire Regions Covered, Global (1 of 2)
• Figure 9-3: Interventional Coronary Guidewire Regions Covered, Global (2 of 2)
• Figure 9-4: Total Angioplasty/PCI Procedures by Region, Global, 2019 - 2029
• Figure 9-5: Angioplasty/PCI Procedures by Country, North America, 2019 - 2029
• Figure 9-6: Angioplasty/PCI Procedures by Country, Latin America, 2019 - 2029 (1 of 2)
• Figure 9-7: Angioplasty/PCI Procedures by Country, Latin America, 2019 - 2029 (2 of 2)
• Figure 9-8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 - 2029
• Figure 9-9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2)
• Figure 9-10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2)
• Figure 9-11: Angioplasty/PCI Procedures by Country, Middle East, 2019 - 2029
• Figure 9-12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3)
• Figure 9-13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3)
• Figure 9-14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3)
• Figure 9-15: Angioplasty/PCI Procedures by Country, Africa, 2019 - 2029
• Figure 9-16: Interventional Coronary Guidewire Market, Global, 2019 - 2029
• Figure 9-17: Units Sold by Region, Interventional Coronary Guidewire Market, Global, 2019 - 2029
• Figure 9-18: Average Selling Price by Region, Interventional Coronary Guidewire Market, Global, 2019 - 2029 (US$)
• Figure 9-19: Market Value by Region, Interventional Coronary Guidewire Market, Global, 2019 - 2029 (US$M)
• Figure 9-20: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022